Deng and colleagues found that METTL14 was downregulated in postmenopausal osteoporotic women and overexpression of METTL14 can suppress osteoclast formation to ameliorate osteoporosis by stabilizing GPX4 [133]. Here, METTL14 is linked to osteoporosis.